Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Cigna Group’s stock clocked out at $273.57, down -1.34% from its previous closing price of $277.28. In other words, the price has decreased by -$1.34 from its previous closing price. On the day, 1.98 million shares were traded. CI stock price reached its highest trading level at $278.6926 during the session, while it also had its lowest trading level at $273.27.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Buy rating and assigned the stock a target price of $370. On February 06, 2025, Bernstein Downgraded its rating to Mkt Perform which previously was Outperform but kept the price unchanged to $323. On June 26, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $400.Piper Sandler initiated its Overweight rating on June 26, 2024, with a $400 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 03 ’25 when Cordani David bought 4,134 shares for $241.88 per share. The transaction valued at 999,916 led to the insider holds 157,935 shares of the business.
Evanko Brian C sold 5,368 shares of CI for $1,610,400 on Oct 03 ’25. The insider now owns 51,182 shares after completing the transaction at $300.00 per share. On Oct 03 ’25, another insider, Evanko Brian C, who serves as the Officer of the company, bought 5,368 shares for $300.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CI now has a Market Capitalization of 73077612544 and an Enterprise Value of 100418609152. As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.07, and their Forward P/E ratio for the next fiscal year is 8.94. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.27 while its Price-to-Book (P/B) ratio in mrq is 1.74. Its current Enterprise Value per Revenue stands at 0.375 whereas that against EBITDA is 8.62.
Stock Price History:
The Beta on a monthly basis for CI is 0.26, which has changed by -0.18312931 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, CI has reached a high of $350.00, while it has fallen to a 52-week low of $239.51. The 50-Day Moving Average of the stock is -3.96%, while the 200-Day Moving Average is calculated to be -10.08%.
Shares Statistics:
It appears that CI traded 1.91M shares on average per day over the past three months and 1786590 shares per day over the past ten days. A total of 266.60M shares are outstanding, with a floating share count of 262.79M. Insiders hold about 1.62% of the company’s shares, while institutions hold 90.33% stake in the company. Shares short for CI as of 1763078400 were 3934852 with a Short Ratio of 2.06, compared to 1760486400 on 3776937. Therefore, it implies a Short% of Shares Outstanding of 3934852 and a Short% of Float of 1.95.
Dividends & Splits
With its trailing 12-month dividend rate of 5.93, CI has a forward annual dividend rate of 5.93. Against a Trailing Annual Dividend Yield of 0.021386323. The stock’s 5-year Average Dividend Yield is 1.49. The current Payout Ratio is 46.19% for CI, which recently paid a dividend on 2025-09-04 with an ex-dividend date of 2025-12-04. Stock splits for the company last occurred on 2007-06-05 when the company split stock in a 3:1 ratio.
Earnings Estimates
A comprehensive evaluation of Cigna Group (CI) is underway, with the input of 22.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $7.3, with high estimates of $7.86 and low estimates of $6.51.
Analysts are recommending an EPS of between $29.76 and $29.0 for the fiscal current year, implying an average EPS of $29.62. EPS for the following year is $30.75, with 24.0 analysts recommending between $33.2 and $29.96.
Revenue Estimates
In. The current quarter, 11 analysts expect revenue to total $69.3B. It ranges from a high estimate of $74.72B to a low estimate of $65.32B. As of. The current estimate, Cigna Group’s year-ago sales were $65.68BFor the next quarter, 11 analysts are estimating revenue of $67.13B. There is a high estimate of $71.2B for the next quarter, whereas the lowest estimate is $64.19B.
A total of 14 analysts have provided revenue estimates for CI’s current fiscal year. The highest revenue estimate was $277.15B, while the lowest revenue estimate was $253.3B, resulting in an average revenue estimate of $269.79B. In the same quarter a year ago, actual revenue was $247.1BBased on 14 analysts’ estimates, the company’s revenue will be $282.67B in the next fiscal year. The high estimate is $306.37B and the low estimate is $263.33B.
